51
Participants
Start Date
January 31, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
January 31, 2016
PINTA 745
"PINTA 745 will be administered once weekly by IV infusion.~Cohort dose schedules:~* 3mg/kg weekly for 12 weeks~* 3mg/kg for 3 weeks, followed by 1mg/kg for 9 weeks~* 6mg/kg for 3 weeks, followed by 2mg/kg for 9 weeks"
Placebo
"Placebo will be administered once weekly by IV infusion.~Cohort dose schedules:~* 3mg/kg weekly for 12 weeks~* 3mg/kg for 3 weeks, followed by 1mg/kg for 9 weeks~* 6mg/kg for 3 weeks, followed by 2mg/kg for 9 weeks"
Orlando Clinical Research Center, Orlando
Vanderbilt University Medical Center, Nashville
DaVita Clinical Research, Minneapolis
Clinical Advancement Center, PLLC, San Antonio
DaVita Clinical Research, Lakewood
University of Washington, Seattle
Lead Sponsor
Pinta Biotherapeutics
INDUSTRY